Rebecca is a Vice President at DRI Capital, a leading life sciences investment firm based in Toronto, where she focuses on sourcing and supporting investments in pharmaceutical royalties. Prior to DRI Capital, Rebecca worked for several biotechnology companies in business development roles and at BMO Capital Markets in biotechnology equity research. She graduated with a B.Sc. in Pharmacology and Toxicology from Western University and an MBA from The Richard Ivey School of Business.
Vice President, DRI Capital